We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018

By LabMedica International staff writers
Posted on 01 Aug 2018
Print article
Image: The Glycated Albumin (GA) assay kit (Photo courtesy of EKF Diagnostics).
Image: The Glycated Albumin (GA) assay kit (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, UK), a global in vitro diagnostics company, highlighted its new Stanbio Chemistry Glycated Albumin (GA) assay kit and its newly FDA cleared DiaSpect Tm hemoglobin point of care (POC) analyzer at the AACC 2018 Clinical Lab Expo held in Chicago, Illinois, from July 29 to August 2. AACC is the world’s largest exposition for clinical laboratory products and services.

EKF Diagnostics manufactures POC and central laboratory technology, including tests for hemoglobin, HbA1c, glucose, lactate and a range of chemistry reagents. The company’s POC blood analyzers aid the diagnosis of anemia, diabetes and associated conditions, and its products are used by healthcare professionals in blood banks, GP surgeries, diabetes clinics, pharmacies, sports medicine, emergency rooms and laboratories.

At AACC 2018, EKF highlighted the Stanbio GA assay, which has FDA 510(k) clearance for sale in the US. The Stanbio Chemistry GA assay uses an enzymatic method with liquid reagents and does not require preparation. It can be used on compatible open channel clinical chemistry analyzers and expresses results as a ratio of GA to Albumin in mmol/mol from a small amount of blood serum.

EKF also demonstrated the use of its newly FDA 510(k) cleared and CLIA waived DiaSpect Tm hemoglobin analyzer at this year’s AACC. DiaSpect Tm analyzes whole blood from a sampling microcuvette designed to collect a blood sample from any angle without forming air bubbles, thus minimizing the need to repeat the testing procedure. DiaSpect Tm delivers lab quality hemoglobin results in about one second of the microcuvette being placed in the analyzer, making it the world’s fastest hemoglobin analyzer and ideal for efficient patient health checks and anemia screening at the POC. The hand-held and reagent free system is suitable and cleared for use in POC and Certificate of Waiver settings, including physician’s offices, clinics and other non-traditional laboratory locations.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.